Analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of NASDAQ:SRNE opened at $0.02 on Monday. The stock has a fifty day simple moving average of $0.02 and a two-hundred day simple moving average of $0.05. Sorrento Therapeutics has a 12-month low of $0.00 and a 12-month high of $0.42.
Sorrento Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- What is the Australian Securities Exchange (ASX)
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- 3 Tickers Leading a Meme Stock Revival
- Hilton Demonstrates Asset Light is Right for Investors
- Industrial Products Stocks Investing
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.